Shows
Naučíme AI PodcastAI ve fotce a videu – od chytrých foťáků po náhled za minutu | Filip KroutilV této epizodě Naučíme AI podcastu je hostem Filip Kroutil – fotograf, kameraman a člověk, který u nás stojí za produkcí celého podcastu. Povídáme si o tom, kde už dnes AI reálně šetří čas v kreativní práci: od chytrých funkcí ve foťácích (AI ostření a rozpoznávání objektů), přes nástroje na úpravy fotek a videa, až po praktické workflow, které z rutiny udělá automat.Filip sdílí konkrétní hack: postavil si GPT asistenta na náhledy, kterému dal svoje šablony a pravidla...
2026-05-2528 min
Naučíme AI PodcastCloud vs. lokální AI: co vyhraje a proč | Milan PokornýV této epizodě Naučíme AI podcastu je hostem Milan Pokorný – programátor a lektor umělé inteligence. Díl je víc freestyle a jde po tom, co dneska reálně pálí firmy i vývojáře: budeme AI používat v cloudu, nebo lokálně ve firmě / doma?Milan vysvětluje, proč je cloud zatím default, ale proč zároveň roste tlak na to mít modely „u sebe“: data security je pro spoustu organizací deal breaker (typicky banky a velké korporáty). Z druhé strany je tu tvrdá ekonomika: provoz velkých m...
2026-05-1830 min
Naučíme AI PodcastKONTEXT > PROMPT: jak učit firmu používat AI (a co funguje v praxi) | Jan PlojharV této epizodě Naučíme AI podcastu je hostem Jan Plojhar z rodinné firmy s tradicí od roku 1888. Povídáme si o tom, jak zavádět AI do výrobní firmy tak, aby to nebylo FOMO ani „nasazení shora“, ale postupné budování schopnosti lidí používat AI v každodenní práci.Jan otevřeně říká, že u nich nejde primárně o to „nasadit AI nástroj do firmy“. Spíš se snaží naučit lidi AI používat: odbourat blokery, ukázat praktické use-casy a vychovat ve firmě „hrdiny“, kteří pak dokážou strhnout os...
2026-05-0431 min
Naučíme AI PodcastPoužívejte AI: proč bez ní bude těžké se uplatnit | Jan ŠvecV této epizodě Naučíme AI podcastu je hostem Jan Švec — výzkumník řečových technologií (ZČU) a člověk, který AI řeší napříč obory: školství, firmy, biotechnologie i digital humanities.Honza jde proti proudu: studenty i učitele aktivně podporuje, aby AI používali. Ne jako zkratku k výsledku, ale jako parťáka, jehož výstupy musí student chápat a umět obhájit. Ukazuje, jak s AI pracují na univerzitě v týmových projektech, jak vyučující využívají AI k přípravě a aktualizaci přednášek a jak vypadá pr...
2026-04-2733 min
Naučíme AI PodcastKonec Excel pekla: low-code aplikace bez vývoje + AI, která zrychlí práci s daty | Vratislav MorkusV této epizodě Naučíme AI podcastu je hostem Vratislav Morkus z firmy Tabidoo — obchodní ředitel a spolumajitel. Vratislav má za sebou roky z enterprise IT (včetně architektury ve skupině Dr.Max) a sdílí know-how z praxe: jak přemýšlet o procesech, datech a AI tak, aby to firmě přineslo měřitelné výsledky, ne další chaos.Tabidoo je low-code platforma, ve které si firmy staví interní aplikace (CRM, projektové řízení, onboarding, fakturace…) bez klasického vývoje a mohou je průběžně upravovat podle toho, jak se mění proces...
2026-04-2033 min
Naučíme AI PodcastAI web za den? Mýty, SEO penalizace a proč musí být nad textem kurátor | Martin ValutV této epizodě Naučíme AI podcastu je hostem Martin Valut z Profit Builders. Řešíme, jak AI reálně ovlivnila tvorbu webů, marketing a SEO – a proč se po prvotní panice („weby se budou dělat samy“) ukázalo, že AI je hlavně pomocník v rukách odborníka, ne náhrada řemesla.Martin popisuje i odvrácenou stranu: klienti dnes přicházejí s „radami z chatu“ a Vy musíte umět argumentovat, stát si za svojí prací a vysvětlit kontext. Bavíme se o tom, proč nestačí vy...
2026-04-1335 min
Naučíme AI PodcastAI ve filmu a kreativní práci: co se změní na natáčení, postprodukci i nápadech | Daniel HabrdaV této epizodě Naučíme AI podcastu je hostem Dan Habrda, spoluzakladatel produkční společnosti NuArt a autor filmu Samhain. Bavíme se o tom, jak AI ovlivní kreativní práci a hlavně filmařinu: co změní na preprodukci, natáčení i postprodukci, kde bude obrovské zrychlení a kde naopak vzniknou úplně nové limity a otázky.Dan zároveň přináší důležitou myšlenku: kreativita je jako sval. Když ji přestanete trénovat (protože „to udělá AI“), můžete o část schopnosti tvořit pos...
2026-04-0628 min
Naučíme AI PodcastBrand v éře AI: buďte konzistentní všude, nebo zmizíte | Martin HrabánekV této epizodě Naučíme AI podcastu je hostem Martin Hrabánek — brand designer, který propojuje brand strategii, vizuální identitu a UX/UI do jednoho funkčního celku. Jdeme rovnou do praxe: jak si z AI udělat „brand policajta“ na konzistenci komunikace a proč AI zároveň mění vyhledávání značek (a tím i to, co musí být na webu).Bavíme se o tom, kde AI v brandu nejvíc škodí, když se používá bez systému: rozpad tónu značky, generické texty, nekonzis...
2026-03-3029 min
Naučíme AI PodcastKonec ruční práce ve firmách: procesní architektura + AI v praxi | Michal ČernýV této epizodě Naučíme AI podcastu je hostem Michal Černý, procesní architekt ve Wexia. Bavíme se o tom, proč většinu firemního času nežere „nedostatek lidí“, ale chaos v procesech, ruční práce a špatně tekoucí informace – a jak k tomu přistoupit tak, aby automatizace a AI přinesly reálný dopad.Michal ukazuje systémový pohled: nejdřív pojmenovat, jak práce ve firmě teče, zjednodušit to, co je zbytečné, a teprve pak automatizovat. Protože AI je zesilovač: když máte dobrý proces, zryc...
2026-03-2328 min
MARTIN ČAPO PODCAST49. Ako prenajať byt bezpečne: Garantovaný prenájomChcete prenajať byt bezpečne a minimalizovať riziko problémového nájomcu? V tejto epizóde rozoberáme, na čo si dať pozor pri prenájme bytu, ktoré faktory rozhodujú pri kúpe investičného bytu a ako prebieha preverenie nájomcu v praxi.V epizóde sa dozviete:✅ Ktoré faktory sú najdôležitejšie pri kúpe investičného bytu.✅ Ako sa líši Garantovaný prenájom od klasického prenájmu a pre koho je určený.✅ Ako v RIEŠIME BÝVANIE prebieha výber a preverenie nájomcu.✅ Na čo myslieť, keď chcete pr...
2026-03-1957 min
Tvoříme EvropuBarbora Novotná: Evropský parlament vás vybaví vzpomínkami, na které jen tak nezapomenete.Barbora Novotná je naše bývalá kolegyně a stážistka, která si prošla Schumanovou stáží v Evropském parlamentu. V nejnovějším díle podcastu Tvoříme Evropu jsme s ní probrali stážistický život z praktické stránky.Jak se v Bruselu hledá ubytování? Na co si dát pozor? Jak je to s dopravou? A co je největší výhoda a nevýhoda života v Bruselu?Poslechněte si nový díl podcastu Tvoříme Evropu!Časovky témat:0:43 Proč zrovna Evropský parlament? 2:12 Pokryl stážisický plat náklady na život v...
2026-03-1324 min
Naučíme AI PodcastMladá generace a umělá inteligence: Co nás čeká? | Jonáš TekelVe druhé epizodě podcastu Naučíme AI se díváme na umělou inteligenci očima mladé generace. Mladí AI používají denně a přirozeně — ale znamená to, že jí opravdu rozumí?Bavíme se o tom, jestli AI ubližuje kreativní tvorbě, jaké profese může reálně ohrozit, proč má smysl poslouchat i starší generace a jestli AI pracuje za nás, nebo pro nás. Dojde i na nejčastější mýty, generovaný obsah a otázku, jestli nám AI skutečně vezme práci.Epizoda o realitě, tempu změn a tom, co nás čeká v nejbl...
2026-03-0933 min
Springer Health+ IME: Podcast to PracticeThe patient voice | S9E4SLE: Translating Guidelines into Practice
Led by Prof. Martin Aringer and Dr. Wiebke Troll
A one-to-one conversation between an expert and a patient advocate, focusing on lived experience, treatment adherence, and shared decision-making.
Watch the all 4 video discussions at https://sle-guidelines-to-practice.ime.springermedicine.com/
Intended for healthcare professionals only.
AstraZeneca has provided an educational grant towards this independent program.
© 2026 Springer Healthcare Ltd. Springer Health+ IME is part of Springer Nature. All rights reserved.
2026-02-1021 minSpringer Health+ IME: Podcast to PracticeOvercoming implementation challenges | S9E3SLE: Translating Guidelines into Practice
Led by Prof. Martin Aringer, Prof. Marta Mosca and Dr. Johanna Mucke
A discussion on regional disparities, barriers to guideline adoption, and practical solutions.
Watch the all 4 video discussions at https://sle-guidelines-to-practice.ime.springermedicine.com/
Intended for healthcare professionals only.
AstraZeneca has provided an educational grant towards this independent program.
© 2026 Springer Healthcare Ltd. Springer Health+ IME is part of Springer Nature. All rights reserved.
2026-02-1024 minSpringer Health+ IME: Podcast to PracticeStandardising disease activity measurement | S9E2SLE: Translating Guidelines into Practice
Led by Prof. Martin Aringer and Dr. Johanna Mucke
Learn about validated tools like LLDAS and DORIS, and how to integrate them into routine care.
Watch the all 4 video discussions at https://sle-guidelines-to-practice.ime.springermedicine.com/
Intended for healthcare professionals only.
AstraZeneca has provided an educational grant towards this independent program.
© 2026 Springer Healthcare Ltd. Springer Health+ IME is part of Springer Nature. All rights reserved.
2026-02-1028 minSpringer Health+ IME: Podcast to PracticeGuideline recommendations and the treat-to-target approach | S9E1SLE: Translating Guidelines into Practice
Led by Prof. Martin Aringer and Prof. Marta Mosca
Explore the updated EULAR 2023 guidelines and how to implement treat-to-target strategies in clinical practice.
Watch the all 4 video discussions at https://sle-guidelines-to-practice.ime.springermedicine.com/
Intended for healthcare professionals only.
AstraZeneca has provided an educational grant towards this independent program.
© 2026 Springer Healthcare Ltd. Springer Health+ IME is part of Springer Nature. All rights reserved.
2026-02-1024 minSpringer Health+ IME: Podcast to PracticeKey Ketone Monitoring Updates and Highlights From the ADA 2025 Conference | S8E1Integrating ketone and glucose monitoring for optimized diabetes management
Dr. David Kerr, MBChB, DM, FRCP, FRCPE, highlights key data from the 2025 American Diabetes Association (ADA) conference, relevant to diabetic ketoacidosis (DKA) and ketone monitoring technology. Dr Kerr discusses the clinical implications for DKA management and integrating diabetes technology, including continuous ketone monitoring.
Watch this podcast in video format, and download the companion summary slides at https://diabetes-cgm.ime.springerhealthcare.com/ketone-masterclass/video-podcast/.
Earn free CME credits – visit the complete program website at https://diabetes-cgm.ime.springerhealthcare.com/ketone-masterclass/ and check out the CME-accredited activities on in...
2025-07-0316 minSpringer Health+ IME: Podcast to PracticeEmbracing gMG advances together: ensuring multidisciplinary collaborationAwareness, Advances, Action: Optimizing Outcomes for Patients with Generalized Myasthenia Gravis
In the final episode of the gMG disease dialogues series, Dr. Kelly Gwathmey, MD, and Jude Kings, RGN, discuss the importance of multidisciplinary teamwork in improving outcomes for patients with generalized myasthenia gravis (gMG).
To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The series features expert discussion on the new and emerging therapies for gMG, practical insights for integrating treatment advances, and the importance of multidisciplinary collaboration to optimize patient care.
2025-06-3024 minSpringer Health+ IME: Podcast to PracticeAdvances in gMG: implications for practiceAwareness, Advances, Action: Optimizing Outcomes for Patients with Generalized Myasthenia Gravis
In the third episode of the gMG disease dialogues series, Dr. Kelly Gwathmey, MD, and Dr. Sithara Ramdas, MD, discuss the evolving treatment landscape, pediatric-specific treatment considerations, diagnostic vigilance and how to assess and introduce newer therapies into practice, including advances into personalized patient management in generalized myasthenia gravis (gMG).
To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The series features expert discussion on the new and emerging therapies for gMG, practical...
2025-06-2420 minSpringer Health+ IME: Podcast to PracticeNew and emerging therapies in gMG: going upstream, T-cell and B-cell targeted therapiesAwareness, Advances, Action: Optimizing Outcomes for Patients with Generalized Myasthenia Gravis
In the second half of this two-part episode, Dr. Kelly Gwathmey, MD, and Dr. Pushpa Narayanaswami, MD, FAAN, discuss the importance of understanding the evolving therapeutic landscape for gMG. They explore the latest B-cell and T-cell targeted therapies, including monoclonal antibodies, CAR-T cell approaches, and small molecule inhibitors, with insights into clinical trial data, mechanisms of action, and real-world considerations for patient-centered care.
To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The...
2025-06-1626 minSpringer Health+ IME: Podcast to PracticeNew and emerging therapies in gMG: FcRn receptor antagonists and complement inhibitionAwareness, Advances, Action: Optimizing Outcomes for Patients with Generalized Myasthenia Gravis
In the first half of this two-part episode, Dr. Kelly Gwathmey, MD, and Dr. Pushpa Narayanaswami, MD, FAAN, first discuss the evolving landscape of generalized myasthenia gravis (gMG) treatment, including the foundational role of conventional immunotherapies and the emergence of novel agents like FcRn receptor antagonists and complement inhibitors. Learn about the mechanisms, clinical trial data, and practical considerations for integrating these therapies into patient care.
To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare...
2025-06-1623 minSpringer Health+ IME: Podcast to PracticeUnderstanding gMGAwareness, Advances, Action: Optimizing Outcomes for Patients with Generalized Myasthenia Gravis
In this first episode of the “gMG disease dialogues” series, host Dr. Kelly Gwathmey, MD, and guest speaker Dr. Sithara Ramdas, MD, discuss adult and pediatric generalized myasthenia gravis (gMG), specifically:
Epidemiology
Symptoms and diagnosis
Pathogenesis
Unmet needs and challenges with traditional therapies
To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The series features expert discussion on the new and emerging therapies for gMG, practical insights for integrating treatment advances, and the impo...
2025-06-1019 minSpringer Health+ IME: Podcast to PracticeVoices of gMG: enhancing patient-centric careAwareness, Advances, Action: Optimizing Outcomes for Patients with Generalized Myasthenia Gravis
In this patient-physician conversation, Janel Worcester-Brown and Dr. Kelly Gwathmey, MD, engage in compelling and candid discussion of the realities of living with generalized myasthenia gravis (gMG) and the challenges patients face navigating their healthcare journey.
Together, they reveal real-world patient perspectives combined with expert provider insights, to uncover the lived experiences of patients with generalized myasthenia gravis (gMG), the unmet needs and gaps in care, and how embracing a patient-centric approach and shared decision-making can make a difference.
To access the interactive video-based...
2025-06-0323 min
MARTIN ČAPO PODCAST27. Prognóza realitného trhu pre rok 2025Ako bude vyzerať vývoj cien nehnuteľností na Slovensku v roku 2025? Môžeme očakávať stabilizáciu, pokles alebo ďalší nárast?Existujú isté riziká, ktoré by tento rok mohli spôsobiť neočakávané výkyvy?Ak by mal Martin Čapo dať jednu jedinú radu kupujúcim a predávajúcim nehnuteľností pre rok 2025, aká by bola? Viac o službách, ktoré poskytuje realitná kancelária RIEŠIME BÝVANIE: https://riesimebyvanie.sk/Ak máte akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk Pridajte sa a...
2025-01-1625 minSpringer Health+ IME: Podcast to PracticeKey CGM Updates and Highlights from the EASD 2024 Conference | S3E3Techniques for implementing CGM in primary care
In this episode, Dr. Jennifer Green dives into several sessions from the EASD 2024 meeting held in Madrid, Spain (September 9-13, 2024), covering topics on the impact of CGM use in T2D on hemoglobin A1C in patients using insulin and non-insulin therapies; hospitalization and ER rates; in non-ICU hospitalized patients; in hospitalized sub-populations of patients who had undergone cardiac surgery, and in sub-populations who had diabetic ketoacidosis. In addition, Dr. Green also covered the impact of hyperglycemia on one-year mortality in older patients using insulin, as well as a new glucose monitoring...
2024-10-0325 minSpringer Health+ IME: Podcast to PracticeKey CGM Updates and Highlights from the ADA 2024 Conference | S3E2Techniques for implementing CGM in primary care
In this episode, Dr. Eugene Wright, Jr. dives into several sessions from the recent ADA meeting held in Orlando, Florida cpvering topics including New Technology- Equity and Access; The Role of the Interdisciplinary Team in Technology Onboarding in Primary Care; CGM New Technology; and CGM Implementation in Primary Care Practices
To learn more about the full program on CGM use in Primary Care, visit https://diabetes-cgm.ime.springerhealthcare.com/techniques/
This program is made possible thanks to an independent educational grant from Abbott.
Intended for healthcare...
2024-07-0418 min
MARTIN ČAPO PODCAST20. Marketing realitnej kancelárieV čom je marketing nehnuteľností špecifický? Cieľová skupina v tejto oblasti je nesmierne široká. Ako na ňu správne cieliť? Je potrebné, aby si jednotliví makléri budovali svoju osobnú značku alebo stačí, ak ich svojou značkou zastreší kancelária? A čo náš obľúbený Jožko Mrkvička, zvládne to aj on? Odpovedá marketingová manažérka pre Riešime bývanie, Lucia Gáborová.Viac o tom, kto je Martin Čapo: https://riesimebyvanie.sk/martin-capo/ Ak máte akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk Pridajte sa...
2024-05-3018 min
Tvoříme EvropuVěra Jourová: „EU je stabilní síla, která se vždycky zastává slabších.“Ve speciálním vydání podcastu Tvoříme Evropu přivítáme místopředsedkyni Evropské komise a eurokomisařku pro hodnoty a transparentnost, Věru Jourovou. Společně se ohlédneme za jejím desetiletým působením v Evropské komisi. Zastavíme se u jejích úspěchů, cenných zkušeností a nahlédneme také do běžného pracovního dne české eurokomisařky.
Co by Věra Jourová vzkázala novému kolegiu Komise? Kam povedou její další kroky? A má raději české nebo belgické pivo? To vše a mnohem více se dozvíte v této epizodě podcastu T
2024-05-2726 min
MARTIN ČAPO PODCAST18. Ako čo najlepšie prenajať byt? Ako sa v najbližšom období budú vyvíjať hypotekárne sadzby? Oplatí sa teraz 1-ročná fixácia alebo treba fixovať na dlhšie? Do akej miery sa táto téma dotýka prenájmu nehnuteľností a ako zamiešava karty nová služba Garantovaný prenájom?Odpovedá hypotekárny špecialista realitnej kancelárie Riešime bývanie, Samuel Šiška. Ak máte na Martina Čapa akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk Pridajte sa aj vy do nášho t...
2024-04-2522 min
MARTIN ČAPO PODCAST18. Ako čo najlepšie prenajať byt?Ako sa v najbližšom období budú vyvíjať hypotekárne sadzby? Oplatí sa teraz 1-ročná fixácia alebo treba fixovať na dlhšie? Do akej miery sa táto téma dotýka prenájmu nehnuteľností a ako zamiešava karty nová služba Garantovaný prenájom?Odpovedá hypotekárny špecialista realitnej kancelárie Riešime bývanie, Samuel Šiška. Ak máte na Martina Čapa akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk Pridajte sa aj vy do nášho...
2024-04-2522 minSpringer Health+ IME: Podcast to PracticeKey CGM Updates and Highlights from the ATTD 2024 Conference | S3E1Techniques for implementing CGM in primary care
In this episode, Dr. Rozalina McCoy dives into three sessions from the recent ATTD meeting held in Florence, Italy: Parallel Session 2: CGM Diabetes Quality Measures; Parallel Session 20: CGM Guided Precision Diabetes Management; and Parallel Session 3: Hypoglycemia – Any Progress?
To learn more about the full program on CGM use in Primary Care, visit diabetes-cgm.ime.springerhealthcare.com
This program is made possible thanks to an independent educational grant from Abbott.
Intended for healthcare professionals only.
© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nat...
2024-04-1725 min
MARTIN ČAPO PODCAST16. Prečo je vzdelávanie pre makléra dôležité? 16. Prečo je vzdelávanie pre makléra dôležité? Čo odlišuje maklérov, ktorí sa priebežne vzdelávajú, od tých druhých? Ako musí maklér na nadobudnutých vedomostiach stavať, aby robil pri svojej práci ďalší progres? Stačia mu na to skúsenosti? Odpovedá manažérka pre vzdelávanie realitnej kancelárie Riešime bývanie, Silvia Čelková. Viac o tom, kto je Martin Čapo: https://riesimebyvanie.sk/martin-capo/Ak máte akékoľvek otázky, môžete nám ich poslať na poradna@r...
2024-03-2826 min
MARTIN ČAPO PODCAST16. Prečo je vzdelávanie pre makléra dôležité?16. Prečo je vzdelávanie pre makléra dôležité? Čo odlišuje maklérov, ktorí sa priebežne vzdelávajú, od tých druhých? Ako musí maklér na nadobudnutých vedomostiach stavať, aby robil pri svojej práci ďalší progres? Stačia mu na to skúsenosti? Odpovedá manažérka pre vzdelávanie realitnej kancelárie Riešime bývanie, Silvia Čelková. Viac o tom, kto je Martin Čapo: https://riesimebyvanie.sk/martin-capo/Ak máte akékoľvek otázky, môžete nám ich poslať na poradna@r...
2024-03-2826 min
MARTIN ČAPO PODCAST14. Umelá inteligencia v realitnom bizniseNahradí AI ľudí pri práci realitného makléra alebo pri práci všeobecne? Budú musieť makléri v budúcnosti AI nástroje používať alebo sa zaobídu aj bez nich?Je AI strašiak, ktorého sa máme báť? Na tieto ale aj ďalšie otázky odpovedá nadšenec umelej inteligencie, realitný maklér a manažér regiónov v Riešime bývanie, Vladimír Gábor. Ak máte na Martina Čapa akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk ...
2024-02-2236 min
MARTIN ČAPO PODCAST14. Umelá inteligencia v realitnom biznise Nahradí AI ľudí pri práci realitného makléra alebo pri práci všeobecne? Budú musieť makléri v budúcnosti AI nástroje používať alebo sa zaobídu aj bez nich?Je AI strašiak, ktorého sa máme báť? Na tieto ale aj ďalšie otázky odpovedá nadšenec umelej inteligencie, realitný maklér a manažér regiónov v Riešime bývanie, Vladimír Gábor. Ak máte na Martina Čapa akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk ...
2024-02-2236 min
Diabetes Knowledge into Practice PodcastPersonalisation of therapy for people with type 2 diabetes and cardiovascular disease riskJoin Prof. Francesco Giorgino and Dr. Darren McGuire as they discuss personalisation of treatment for patients with both type 2 diabetes and cardiovascular disease.
For more free education, go to diabetes.knowledgeintopractice.com, where you can see all past episodes of the podcast as well as other free CME resources. Follow us on Twitter (@dkipractice) or connect on LinkedIn.
Faculty disclosures
Prof. Francesco Giorgino
Grants or contracts: Eli Lilly, Roche Diabetes Care
Consulting: Eli Lilly, Novo Nordisk
Honoraria for lectures, presentations and education events: Astra-Zeneca, Boehringer-Ingelheim
Advisory boards: Eli Lilly, Lifescan, Merck Sharp & Dohme, Medimmu...
2024-02-1411 minDiabetes Knowledge into Practice PodcastEffective strategies for encouraging behaviour change
Join Prof. Francesco Giorgino and Dr. Shehla Shaikh as they discuss strategies to help support type 2 diabetes patients during cultural events, such as observation of Ramadan.
For more free education, go to diabetes.knowledgeintopractice.com, where you can see all past episodes of the podcast as well as other free CME resources. Follow us on Twitter (@dkipractice) or connect on LinkedIn.
Prof. Francesco Giorgino
Grants or contracts: Eli Lilly, Roche Diabetes Care
Consulting: Eli Lilly, Novo Nordisk
Honoraria for lectures, presentations and education events: Astra-Zeneca, Boehringer-Ingelheim
Advisory boards: Eli Lilly, Lifescan, Merck Sharp & Dohme, Medi...
2024-02-1414 min
MARTIN ČAPO PODCAST13. Investícia do nehnuteľností v roku 2024: Vyplatí sa alebo nie?Všeobecný predpoklad je, že najdôležitejšie pri nadobúdanej nehnuteľnosti je jej investičné hľadisko. Je tento pohľad správny? Akú chybu najčastejšie robia začínajúci investori? Ak si neviem sám vybrať investičnú nehnuteľnosť, na koho sa mám obrátiť, aby mi poradil?Odpovedá CEO realitnej kancelárie Riešime bývanie, Martin Čapo. Ak máte na Martina Čapa akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk Pridajte sa aj vy do nášh...
2024-02-0842 min
MARTIN ČAPO PODCAST13. Investícia do nehnuteľností v roku 2024: Vyplatí sa alebo nie? Všeobecný predpoklad je, že najdôležitejšie pri nadobúdanej nehnuteľnosti je jej investičné hľadisko. Je tento pohľad správny? Akú chybu najčastejšie robia začínajúci investori? Ak si neviem sám vybrať investičnú nehnuteľnosť, na koho sa mám obrátiť, aby mi poradil?Odpovedá CEO realitnej kancelárie Riešime bývanie, Martin Čapo. Ak máte na Martina Čapa akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk Pridajte sa aj vy do nášho...
2024-02-0842 minDiabetes Knowledge into Practice PodcastWorld Diabetes Day – Overcoming Cultural Obstacles to Personalise Diabetes CareJoin Prof. Francesco Giorgino and Dr. Alice Cheng for a discussion on the importance of being culturally sensitive during shared decision-making in type 2 diabetes care.
For more free education, go to diabetes.knowledgeintopractice.com, where you can see all past episodes of the podcast as well as other free CME resources. Follow us on Twitter (@dkipractice) or connect on LinkedIn.
Faculty disclosures
Prof. Francesco Giorgino
Grants or contracts: Eli Lilly, Roche Diabetes Care
Consulting: Eli Lilly, Novo Nordisk
Honoraria for lectures, presentations and education ev...
2023-12-1913 minDiabetes Knowledge into Practice PodcastCongress special: Highlights from EASD 2023Join Prof. Francesco Giorgino and Dr. Erika Bezerra Parente as they identify some takeaways from EASD 2023, including data and discussions on treatment non-adherence, SGLT2 inhibitors, and stigma
For more free education, go to diabetes.knowledgeintopractice.com, where you can see all past episodes of the podcast as well as other free CME resources. Follow us on Twitter (@dkipractice) or connect on LinkedIn.
Faculty disclosures
Prof. Francesco Giorgino
Grants or contracts: Eli Lilly, Roche Diabetes Care
Consulting: Eli Lilly, Novo Nordisk
Honoraria for lectures, presentations and education even...
2023-12-1114 min
MARTIN ČAPO PODCAST10. Aká je kariéra realitného makléra v Riešime bývanie?Ktoré kvalifikačné zručnosti a osobnostné predpoklady by mal mať začínajúci realitný maklér?Aké omyly realitní makléri najčastejšie robia a ako sa im vyhnúť?Ako získať a udržať si dobrú povesť a pozitívne referencie vo svete realít?Má Martin Čapo, ako špičkový realitný expert, k téme kariérneho rastu realitných maklérov nejaké tajné tipy? Dozviete sa v podcaste. Ak máte na Martina Čapa akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk
2023-09-2936 min
MARTIN ČAPO PODCAST10. Aká je kariéra realitného makléra v Riešime bývanie? Ktoré kvalifikačné zručnosti a osobnostné predpoklady by mal mať začínajúci realitný maklér?Aké omyly realitní makléri najčastejšie robia a ako sa im vyhnúť?Ako získať a udržať si dobrú povesť a pozitívne referencie vo svete realít?Má Martin Čapo, ako špičkový realitný expert, k téme kariérneho rastu realitných maklérov nejaké tajné tipy? Dozviete sa v podcaste. Ak máte na Martina Čapa akékoľvek otázky, môžete nám ich poslať na poradna@riesimebyvanie.sk
2023-09-2936 min
Oncology Knowledge into Practice PodcastClinical application of next-generation sequencing in advanced thyroid cancerIn today's episode, we welcome Dr. Sandip Patel, who is a Professor of Medical Oncology at the University of California, San Diego, to discuss the evolution of molecular profiling technology, focusing on how next-generation sequencing can help support patients with advanced thyroid cancer, but also how to integrate molecular profiling into clinical practice.
Learning Objective(s):
After completing this educational activity, learners will be able to discuss precision medicine and new technologies, including liquid biopsy
Funding Information:
This independent educational activity is supported by an educational grant from...
2023-09-0412 minOncology Knowledge into Practice PodcastAdapting thyroid cancer guidelines to local care settingsIn today's episode, we welcome Dr. Conor Steuer, which is Associate Professor at the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta, USA, to discuss adaptation of thyroid cancer guidelines to local care settings. We touch on strategies for guideline implementation and how to overcome potential barriers.
Target Audience:
Oncologists, pathologists and other HCPs involved in the diagnosis of RET and TRK cancers, with a focus on community practitioners.
Learning Objective(s):
After completing this educational activity, learners will be able to:
• Recall th...
2023-08-1515 minOncology Knowledge into Practice PodcastThe ESMO 2022 Clinical Practice Guidelines for use of systemic therapy in advanced thyroid careDevelopments in precision medicine have led to a paradigm shift in the management of advanced thyroid cancer. The ESMO Guidelines Committee recently developed a new clinical practice guideline on the use of systemic therapy in this setting.
This episode offers guideline insights into the applications recently approved therapies that have been approved by the FDA and/or the EMA, including cabozantinib, selpercatinib, pralsetinib, and entrectinib. It also provides data updates of previously approved therapies and how guidelines have been adapted accordingly. To answer questions on the 2022 ESMO Clinical Practice Guideline update, we have invited Dr. Ahmad Awada...
2023-03-2115 minDiabetes Knowledge into Practice PodcastConference special: EASD 2022 Highlights | With Prof. Apostolos TsapasThis year’s EASD was a hybrid event, with delegates able to join either in person in Stockholm, or online via the virtual platform. As usual, the congress featured a huge number of presented abstracts, symposia and other sessions. This year also saw the publication of the updated ADA-EASD consensus report on the management of hyperglycaemia in type 2 diabetes.
Join us as we speak to Professor Apostolos Tsapas about his conference highlights, including:
- 2022 ADA-EASD consensus report on the management of hyperglycaemia in type 2 diabetes
- 44-year follow-up results from the UKPDS trial...
2022-11-1418 minDiabetes Knowledge into Practice PodcastPublication special: Data from the SURPASS program | With Prof Carol WyshamThe SURPASS program of phase 3 clinical trials led to the 2022 FDA approval and positive CHMP opinion of the first GIP/GLP-1 receptor agonist, tirzepatide. Join Prof Carol Wysham for an examination of the clinical data from these trials and their potential impact on type 2 diabetes management.
By completing this activity, you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at https://diabetes.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME resources.
Learning...
2022-09-2713 minDiabetes Knowledge into Practice PodcastTailoring GLP-1 RA dosing regimens | With Dr Harpreet BajajHeterogeneity across available glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes means that agents should be prescribed based on patient characteristics and preferences. So how can we best make that decision?
Join Dr Harpreet Bajaj for a discussion of tailoring GLP-1 RA regimens to patient characteristics, including considerations for dosing and treatment intensification.
By completing this activity, you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment.
References available here
Dr Harpreet Bajaj declares the following financial relationships...
2022-09-1214 minDiabetes Knowledge into Practice PodcastFocus on CKD: Latest guidelines and therapies | With Dr David CherneyThe last two years have provided updated guidelines on management of chronic kidney disease in type 2 diabetes alongside new regulatory approvals of pharmacotherapies. In this episode we speak to Dr David Cherney about the implications of these updates and advancements.
By completing this activity, you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at https://diabetes.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME resources.
References available here
Disclosures:
2022-08-2218 minDiabetes Knowledge into Practice PodcastFocus on CVD: How much do we know now? | With Prof. Naveed SattarThe past year has included the release of new guidelines on cardiovascular disease prevention and further data on cardioprotective agents in type 2 diabetes. In this episode we speak to Prof. Naveed Sattar about these guidelines and how best to help people with type 2 diabetes to reduce their cardiovascular risk.
By completing this activity, you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at https://diabetes.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME resources.
2022-08-1218 minDiabetes Knowledge into Practice PodcastAdvances in incretin therapy: dual agonists and beyond | With Prof. Filip KnopThis year saw the regulatory approval of the first dual GIP/GLP-1 dual agonist for type 2 diabetes. With several other multi-agonists in development, what does this mean for clinicians caring for people with type 2 diabetes?
Join Prof. Filip Knop for an overview of these new and emerging agents.
By completing this activity, you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at https://diabetes.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME...
2022-07-1516 min
Diabetes Knowledge into Practice PodcastLatest approaches to supporting weight loss in T2D | With Dr Robert KushnerThe importance of weight loss in type 2 diabetes was a major topic at the recent American Diabetes Association (ADA) 2022 Scientific Sessions. As weight management is a complex issue affected by both genetic and environmental factors, we shed light on the latest advances in obesity care for individuals with type 2 diabetes.
Join us as we examine the effect of lifestyle interventions, metabolic surgery and the latest pharmaceutical agents, and discuss the state of the field with Dr Robert Kushner.
By completing this activity, you can qualify for 0.25 CME credits. To claim your credits, you must listen...
2022-07-0119 minDiabetes Knowledge into Practice PodcastConference special: ADA 2022 | With Prof. Jennifer GreenThe ADA 2022 was full of interesting symposia, updates on ongoing clinical trials, and a draft of an updated ADA-EASD consensus report. This year’s conference also put particular emphasis on weight management in the setting of type 2 diabetes as well as its associated cardiovascular and kidney comorbidities.
Join us as we speak to Professor Jennifer Green about her conference highlights, including:
- Draft ADA-EASD Consensus Report
- Results from the SURMOUNT-1 clinical trial of tirzepatide in people with obesity
- Further data for dual and triple incretin agonists and their potential fu...
2022-06-1717 minDiabetes Knowledge into Practice PodcastNASH: Current and future therapies | With Prof. Philip NewsomeThis is a special episode brought to you in association with Hepatology Knowledge into Practice.
NASH has historically had very few treatment options, with none currently indicated specifically for NASH. But a large number of ongoing clinical trials means that treatment may look different in the future.
Join Professor Philip Newsome for an overview of current treatments in NASH, as well as how treatment may change in the future.
By completing this activity you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the...
2022-06-0714 minDiabetes Knowledge into Practice PodcastPublication special: SUSTAIN FORTE | With Dr Juan Pablo FríasGLP-1 receptor agonists including semaglutide have been shown to offer benefits for glycemic control, weight loss and cardiovascular protection in type 2 diabetes. But where a patient requires more glycemic control, would a higher dose be of help?
The SUSTAIN FORTE trial was a randomized, double-blind, phase 3B trial that aimed to establish whether a higher dose of semaglutide was superior to the highest approved maintenance dose for glycemic control. Join Dr Juan Pablo Frias for a summary of the trial data and its potential implications for clinical practice.
By completing this activity you can qualify...
2022-06-0114 minDiabetes Knowledge into Practice PodcastLatest data on SGLT2is in heart failure | With Prof. Javed ButlerIn late 2020, we published an episode looking at the management of diabetes and heart failure when both present together. Since then, a wealth of evidence has been published on the effects of sodium glucose cotransporter type 2 (SGLT2) inhibitors in people with heart failure with or without type 2 diabetes. These findings have led to expanded indications for some of these agents to include heart failure. Today we will examine these data and their relevance in clinical practice in the setting of type 2 diabetes with heart failure.
Joining us to discuss what these data mean for clinical practice is P...
2022-05-1919 minDiabetes Knowledge into Practice PodcastCloseup on the ADA 2022 Standards of Medical Care | With Prof. Anne PetersThe 2022 Standards of Medical Care in Diabetes is published every year by the American Diabetes Association to reflect the latest available clinical evidence. The most significant updates this year include a lower age to begin screening for prediabetes and diabetes, an increased emphasis on individualization of treatment, and further recommendations around the use of technologies such as continuous glucose monitoring and treatment of obesity.
To hear more about some of these updates and their rationale, we’re joined by Professor Anne Peters, a member of the ADA’s Professional Practice Committee which reviews and updates the Standards.
2022-05-1619 minDiabetes Knowledge into Practice PodcastNASH: Advances in non-invasive screening | With Dr Kenneth CusiThis is a special episode brought to you in association with Hepatology Knowledge into Practice.
NASH occurs in around 20% of individuals with NAFLD, and puts patients at high risk of poor outcomes including cardiovascular events and hepatocellular carcinoma. With people with type 2 diabetes and obesity at significantly increased risk for developing NAFLD, how can we identify those with NASH?
In this podcast episode, we are joined by Dr Kenneth Cusi to discuss how patients can be risk stratified using non-invasive biomarkers and imaging techniques.
By completing this activity you can qualify for 0.25 CME...
2022-05-1614 minDiabetes Knowledge into Practice PodcastUpdate on Covid-19 and diabetes: What more do we know? | With Prof. Partha KarDescription:
A year ago, we published an episode looking at diabetes management in the context of ongoing restrictions in many parts of the world. Since then, a wealth of clinical data has continued to be published on the bidirectional relationship between diabetes and Covid-19, so today we’re taking a closer look at these data.
We’re joined by Professor Partha Kar, National Specialty Advisor, Diabetes for NHS England, to discuss what the data mean for clinical practice.
By completing this activity you can qualify for 0.25 CME credits. To claim your credits, you must...
2022-04-1314 minDiabetes Knowledge into Practice PodcastNASH: What’s behind the link with T2D and obesity? | With Prof. Giulio MarchesiniThis is a special episode brought to you in association with Hepatology Knowledge into Practice.
People with type 2 diabetes or obesity are at higher risk of developing non-alcoholic fatty liver disease (NAFLD) including non-alcoholic steatohepatitis (NASH). Some estimates report a prevalence of NAFLD of 60% in people with type 2 diabetes, rising to 78% in those who also have obesity. So what’s behind this link?
In this podcast episode, Professor Giulio Marchesini explores the relationships between NAFLD, type 2 diabetes and obesity and offers advice for healthcare professionals caring for people with one or more of these conditions....
2022-04-0115 minDiabetes Knowledge into Practice PodcastNASH: Pathogenesis and pathophysiology | With Prof. Zobair YounossiThis is a special episode brought to you in association with Hepatology Knowledge into Practice. Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver disease, of which an advanced form is non-alcoholic steatohepatitis (NASH). But how does this condition develop, and why is it associated with poor outcomes? In this podcast episode, Professor Zobair Younossi discusses the latest evidence on the pathogenesis and pathophysiology of NASH, and how it can lead to poor outcomes.
By completing this module you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully p...
2022-03-0120 min
IME Community PodcastHappy One Year Anniversary, IME! A Year in the Life of IME Community!It's IME Community's One Year Anniversary! Guess what I'm doing to celebrate a year of IME Community building? Making this YouTube video! What else would I be doing? I'm sharing with you all my wins, losses, fails, all the things. I've been a founder of many things and, let me tell you, it's been a year. It's been incredible and so tough in many ways. Coaching teens has been the absolute best part of everything and my biggest joy over the last year. I also wasn't planning on the TikTok growth of the IME Community platform or becoming the...
2022-01-2525 min
IME Community PodcastIME Community Solutions for Children's Health with Jessie Coffey, MS, RDNHello, I’m so excited to launch the IME Community Solutions for Children’s Health Podcast and YouTube series focusing on local solutions, highlighting the impactful work of visionary champions like my first guest, Jessie Coffey, MS, RDN! Want to hear about the time Jessie was working in the School Nutrition Department and one of the middle schools boycotted school lunch? Then, when she worked with the students to ask for their input, specifically, what they wanted for lunch, they demanded, “Lobster, ice cream, and soda!” By the way, I’m dedicating this series to my former non-profit, Teach a Kid to F...
2021-12-1055 min
IME Community PodcastIME TikTok Trolls Strategy: Report. Delete. Block. Repeat as needed.TikTok Trolls are gonna hate, I guess. We can't control that or the first comment they post on our videos. Oh wait. Yes, we can. Report. Delete. Block and then Lather. Rinse. Repeat. That's my strategy. I was coached by the IME Community member teens to only reply and to do so with a video to the outright misinformation that trolls try to spread. Otherwise, ignore. I'm lucky, I suppose, that I usually only have a few haters respond to my videos. They're basement dwelling keyboard screamers, if you will. Cyberbullies looking for a quick power and control hit...
2021-11-0515 min
IME Community PodcastIME UBU for Week 12 of the Reverse Your Insulin Resistance Challenge!• IME/UBU MONDAY o We are talking Relationships and boundaries for Week 12 of the IME Reverse Your Insulin Resistance Challenge o What do relationships and boundaries have to do with reversing your insulin resistance, reaching your health goals and losing weight? I’ve told you before and I’m gonna tell you again this week that taking action on a goal you are setting for yourself is all about your relationship with yourself. You know putting on your oxygen mask first? We have to learn to do that and when we believe or stay attached to fixed and li...
2021-09-2741 min